Flying Brand Ltd's (LON:FBDU) newly-acquired subsidiary, Imaging Biometrics (IB), has inked a distribution agreement with EnvoyAI, an artificial intelligence exchange platform. IB Neuro, which measures blood volume in the brain, and the Delta T1 mapping algorithm, are now available for purchase on the exchange.
Ergomed Plc (LON:ERGO), which provides specialist services to the pharmaceutical industry, enjoyed another year of strong growth in its service business in 2017.
Summit Therapeutics PLC (LON:SUMM, NASDAQ:SMMT) chief executive Glyn Edwards described 2017 as a “landmark year”, though investors are already looking to the third-quarter of this year for the next major milestone. Eagerly anticipated by the investing public are the top-line results for ezutromid, a potential breakthrough treatment for sufferers of Duchenne Muscular Dystrophy (DMD), a fatal wasting disease that affects boys.
An independent technical report to accompany the recent drilling at Landore Resources Limited’s (LON:LND) BAM East gold deposit has indicated 'excellent potential' to expand the size of the resource. Roscoe Postle Associates said there was potential to expand the limits of the deposit at BAM East and to discover zones of additional gold mineralisation along the Junior Lake Shear Zone.
European Metals Holdings Limited (EMH) (LON:EMH) has named Neil Meadows as its chief operating officer, a non-board appointment. The AIM-listed firm said Meadows has previously held the position of chief operating officer at Karara Mining Ltd, managing director of IMX Resources Limited and worked with the Australian Premium Iron Ore Joint Venture on mine infrastructure.
Greatland Gold plc (LON:GGP) has told investors it will advance the Firetower project in Tasmania towards an exploration target of 1mln ounces of gold. It comes after a technical review of the project highlighted potential for a geophysical programme (using induced polarisation) to assist in outlining gold mineralisation in areas untested by previous drilling.
Capital Drilling Limited (LON:CAPD) said it has been awarded a three-year contract with Resolute Mining Limited (ASX:RSG) to provide drilling services in Mali. The drilling solutions company said it would provide surface drilling for exploration and resource development at Resolute’s projects and joint venture operations in the West African nation.
Cabot Energy PLC (LON:CAB) told investors that production in April averaged 950 barrels of oil per day, meanwhile, the measure for the first three months of the year averaged 725 bopd. It is anticipated that another 200 bopd of crude production will be brought online through the second quarter. Big Pic in January.
Bushveld Minerals Limited (LON:BMN) said its Bushveld Energy subsidiary has been experiencing increased requests for electrolyte supply and vanadium redox flow battery technology for energy storage projects.
Auroch Minerals, in which Cadence Minerals Plc (LON:KDNC) has a stake, has announced results from reconnaissance sampling at the Arden base metals project. During reconnaissance field mapping and sampling at the Arden project, extensive sedimentary exhalative-style base metal mineralisation was observed at three of the advanced target areas: Ragless Range, Radford Creek and Kanyaka.
US Oil & Gas PLC (USOIL) has raised US$290,632 of new capital, placing 685,314 new shares at a price of 33.99 Euro cents. The company told investors that the injection of funds will provide additional working capital, including the funding of drilling operations.
Range Resources Ltd (LON:RRL) told investors it has reached an agreement with Colombia’s Agencia Nacional de Hidrocarburos (ANH) to settle all outstanding claims and disputes between ANH and the consortium of Optima Oil Corporation and the company. Previously, in 2016, ANH sought a US$53mln claim in relation to allegations that work commitments weren’t fulfilled and that invalid letters of credit had been presented.
Motif Bio Plc (LON:MFTB) (NASDAQ:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announces that iclaprim-related abstracts are now online for the upcoming 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018) to be held in Madrid, Spain, April 21-24, 2018.